Internal Medicine, Pulmonary Disease · Grand Blanc, MI
NPI
1457308702
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
4
Medicare group memberships
Hospitals
1
Hospital affiliations
8220 S Saginaw St, Suite 800
Grand Blanc, MI, 48439
Phone (810) 695-5864
Groups this clinician bills Medicare through
Medicare paid, 2024
$220K
2,693 services
Medicare patients, 2024
680
Average age 74
Drug cost, 2024
$2.4M
1,845 prescriptions
Company payments, 2025
$786
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Muhammad M Aboudan was code 99233 (hospital e&m - subsequent), 920 times for 304 patients. In total Muhammad M Aboudan billed 2,693 services in 48 codes, and Medicare paid $220K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 920 | 304 | $89.56 | $82K |
| 99291 Critical Care E&M | Facility | 264 | 110 | $162.25 | $43K |
| 99232 Hospital E&M - Subsequent | Facility | 220 | 88 | $59.90 | $13K |
| 99214 Office E&M - Established | Office | 159 | 117 | $89.27 | $14K |
| 99223 Hospital E&M - Initial | Facility | 135 | 130 | $131.58 | $18K |
| 99215 Office E&M - Established | Office | 121 | 80 | $130.89 | $16K |
| 94060 Pulmonary Function Testing | Office | 108 | 101 | $25.52 | $2,756 |
| 94726 Pulmonary Function Testing | Office | 103 | 99 | $37.08 | $3,819 |
| 94729 Pulmonary Function Testing | Office | 102 | 99 | $38.45 | $3,922 |
| 99457 E&M - Miscellaneous | Office | 86 | 13 | $36.59 | $3,147 |
| 99458 E&M - Miscellaneous | Office | 75 | 11 | $29.71 | $2,228 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 44 | 41 | $12.55 | $552 |
| 99213 Office E&M - Established | Office | 34 | 32 | $61.92 | $2,105 |
| 71046 X-ray - Chest | Office | 33 | 31 | $22.44 | $740 |
| 94660 Treatment - Miscellaneous | Office | 23 | 18 | $48.23 | $1,109 |
By year: 2022 $239K for 3,131 services; 2023 $194K for 2,399 services; 2024 $220K for 2,693 services.
Medicare prescription drug claims, 2024
In 2024, the drug Muhammad M Aboudan prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 309 prescriptions and refills. In total Muhammad M Aboudan wrote 1,845 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 309 | 712 | 97 | $432K |
| Montelukast Sodium Generic | 169 | 459 | 60 | $3,545 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 134 | 242 | 54 | $9,082 |
| Furosemide Generic | 98 | 221 | 29 | $605 |
| Prednisone Generic | 68 | 134 | 30 | $515 |
| Ofev Nintedanib Esylate | 65 | 65 | Under 11 | $826K |
| Roflumilast Generic | 58 | 107 | 11 | $6,778 |
| Incruse Ellipta Umeclidinium Bromide | 58 | 128 | 15 | $41K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 57 | 135 | 23 | $59K |
| Ventolin Hfa Albuterol Sulfate | 55 | 107 | 25 | $6,410 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 55 | 77 | 11 | $46K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 55 | 126 | 21 | $15K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 52 | 126 | 18 | $26K |
| Tiotropium Bromide Generic | 48 | 128 | 16 | $52K |
| Combivent Respimat Ipratropium/Albuterol Sulfate | 38 | 75 | Under 11 | $38K |
Brand drugs: 1,044 claims; generic drugs: 801 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Muhammad M Aboudan $786 ($786 in general payments such as food, travel and fees) from 19 companies. The largest payer was GlaxoSmithKline, LLC. with $150.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 9 | $150 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $90.06 |
| United Therapeutics Corporation UTHR | 3 | $67.64 |
| Amgen Inc. AMGN | 3 | $57.11 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $51.36 |
| Genzyme Corporation SNY | 2 | $47.5 |
| Resmed Corp RMD | 2 | $46.7 |
| Inspire Medical Systems, Inc. INSP | 1 | $37.18 |
| Viatris Specialty LLC | 2 | $34.58 |
| Actelion Pharmaceuticals US, Inc. JNJ | 1 | $24.83 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.